Cargando…
SCARA5 inhibits oral squamous cell carcinoma via inactivating the STAT3 and PI3K/AKT signaling pathways
Oral squamous cell carcinoma (OSCC) is a common tumor in the world. Despite the rapid development of medical care, OSCC is also accompanied by high incidence and mortality every year. Therefore, it is still necessary to continuously develop new methods or find new targets to treat OSCC. Previous res...
Autores principales: | Huang, Juan, Lv, Chunhua, Zhao, Baoyu, Ji, Zhongqian, Gao, Zhenran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9921916/ https://www.ncbi.nlm.nih.gov/pubmed/36785765 http://dx.doi.org/10.1515/med-2023-0627 |
Ejemplares similares
-
SCARA5 suppresses the proliferation and migration, and promotes the apoptosis of human retinoblastoma cells by inhibiting the PI3K/AKT pathway
por: Wang, Jinwei, et al.
Publicado: (2021) -
SCARA3 inhibits cell proliferation and EMT through AKT signaling pathway in lung cancer
por: Kim, Jeeho, et al.
Publicado: (2022) -
Identification of SCARA3 with potential roles in metabolic disorders
por: Peng, Hui, et al.
Publicado: (2020) -
FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K/AKT signaling pathway
por: Wang, Xiao, et al.
Publicado: (2021) -
Highly Expressing SCARA5 Promotes Proliferation and Migration of Esophageal Squamous Cell Carcinoma
por: Jumai, Kawuli, et al.
Publicado: (2022)